VERICEL CORPORATION Operating Leases, Future Minimum Payments, Due in Four Years
VERICEL CORPORATION (VCEL) had Operating Leases, Future Minimum Payments, Due in Four Years of $966.00 thousand as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-02-25
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $966.00K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $966.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $4.81M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $4.81M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2019-12-31 | $966.00K 10-K · filed 2020-02-25 |
| 2018-12-31 | $966.00K 10-Q · filed 2019-11-05 |
| 2018-09-30 | $4.81M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $4.81M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $4.59M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $4.56M 10-K · filed 2018-03-05 |
| 2017-09-30 | $4.47M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $4.46M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.42M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.41M 10-K · filed 2017-03-13 |
| 2016-09-30 | $4.32M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.27M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $4.26M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.26M 10-K · filed 2016-03-14 |
| 2015-09-30 | $347.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $260.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $253.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $248.00K 10-K · filed 2015-03-25 |
| 2014-09-30 | $1.32M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.25M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $893.00K 10-K · filed 2014-03-13 |
| 2012-12-31 | $359.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |